Nobori And Uncoated Stent In Coronary Attack

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
Drug-eluting stents reduce rates of restenosis and reintervention, as compared with uncoated stents. Data are limited regarding the safety and efficacy of Nobori (Biolimus A9 Eluting Stent) in primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI). Accordingly, the investigators will compare the outcomes of primary PCI for AMI between patients receiving Nobori versus uncoated stents.
Epistemonikos ID: d591a7e30536941c16f82167b7aec038ba0ba6a7
First added on: May 06, 2024